Bipolar Disorder Clinical Trial
Official title:
A Randomized Controlled Trial of Cognitive Remediation and D-cycloserine for Individuals With Bipolar Disorder
Individuals with bipolar suffer from problems in basic cognitive skills such as memory and
concentration. Unfortunately, there are no current treatments that have been shown to improve
cognitive skills among individuals with bipolar disorder.
Computerized cognitive remediation (CR) is a treatment that has been shown to improve
cognitive skills among individuals with serious mental illnesses other than bipolar disorder,
such as schizophrenia. This treatment involves completing a series of activities on a
computer that have been shown to improve cognitive skills.
D-cycloserine (DCS) is an antibiotic traditionally used in the treatment of tuberculosis.
Recent studies have suggested that this drug may also improve individuals' ability to learn.
Thus, the goal of our study is to examine whether receipt of d-cycloserine increases the
benefit that individuals receive from participation in cognitive remediation.
To test this hypothesis, approximately forty subjects will be randomized to one of two study
arms: [i] CR + DCS or [ii] CR + placebo. We will examine whether d-cycloserine increases the
benefit that individuals with bipolar disorder receive from participation in cognitive
remediation.
Individuals with bipolar disorder suffer from a broad array of cognitive deficits that may
hinder their ability to achieve successful community functioning. Consequently, greater
attention has recently been directed toward the development of strategies to ameliorate these
cognitive deficits. One strategy which has been shown to be successful in this endeavor is
cognitive remediation (CR). This intervention, which is recognized as a "best practice" in
the treatment of serious mental illness, is typically comprised of a series of repeated
exercises delivered by a clinician or via a computer that are designed to improve performance
in cognitive functioning. Yet, despite the promise of cognitive remediation, the benefit of
this intervention among individuals with bipolar disorder has yet to be investigated.
Recently, studies have demonstrated that d-cycloserine (DCS), an N-methyl-D-aspartate
receptor (NMDAR) agonist, may facilitate the learning process for emotional and non-emotional
information in both humans and animals. These results raise the possibility that DCS may
increase the benefits associated with the receipt of cognitive remediation among individuals
with bipolar disorder. To date, we are unaware of any study which has examined whether
concurrent receipt of DCS may increase the benefits produced by cognitive remediation among
individuals with a severe mental illness.
Thus, we propose to complete an exploratory investigation of augmenting cognitive remediation
with DCS among individuals with bipolar disorder. Approximately forty subjects will be
randomized to one of two study arms: [i] CR + DCS; or [ii] CR + placebo. The primary outcome
of interest will be changes in cognitive functioning before and after receipt of the
cognitive remediation intervention. Secondary outcomes of interest will be changes in
symptomatology, social and vocational functioning, and performance of tasks of everyday
living.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT02855762 -
Targeting the Microbiome to Improve Clinical Outcomes in Bipolar Disorder
|
N/A | |
Recruiting |
NCT05915013 -
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
|
Phase 1 | |
Recruiting |
NCT05206747 -
Ottawa Sunglasses at Night for Mania Study
|
N/A | |
Completed |
NCT02513654 -
Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects
|
Phase 1 | |
Recruiting |
NCT06313918 -
Exercise Therapy in Mental Disorders-study
|
N/A | |
Completed |
NCT02304432 -
Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine
|
Early Phase 1 | |
Recruiting |
NCT06197048 -
Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder
|
N/A | |
Completed |
NCT03497663 -
VIA Family - Family Based Early Intervention Versus Treatment as Usual
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Completed |
NCT02212041 -
Electronic Cigarettes in Smokers With Mental Illness
|
N/A | |
Recruiting |
NCT05030272 -
Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings
|
N/A | |
Recruiting |
NCT04298450 -
ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention
|
N/A | |
Active, not recruiting |
NCT03641300 -
Efficacy of Convulsive Therapies for Bipolar Depression
|
N/A | |
Not yet recruiting |
NCT04432116 -
Time and Virtual Reality in Schizophrenia and Bipolar Disorder
|
N/A | |
Terminated |
NCT02909504 -
Gao NARASD Lithium Study
|
Phase 4 | |
Terminated |
NCT02893371 -
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
|
||
Completed |
NCT02970721 -
Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder
|
||
Recruiting |
NCT03088657 -
Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study
|
||
Recruiting |
NCT02481245 -
BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study
|
Phase 2 |